Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06946368 · ClinicalTrials.gov registry record · NA

Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery

A NA study of Total Knee Arthroplasty, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06946368: Recruiting NA study of Total Knee Arthroplasty, sponsored by The Cleveland Clinic.

NCT06946368 is a NA study of Total Knee Arthroplasty that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 60 participants, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06946368, a NA study of Total Knee Arthroplasty, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Intra-articular Posteromedial Surgeon Administered (IPSA) Block in this study describes a new type of medical procedure where a surgeon provides anesthetic medication directly into a specific area inside a knee joint to numb the pain during knee surgery. Intra-articular refers to inside of knee joint, posteromedial refers to the back and inner side of a knee joint, and surgeon administered means a surgeon is performing the procedure. Patients You will be randomly assigned to one of these three treatment groups: Group 1: Patients in this group will receive IPSA block and Local Infiltration Analgesia (LIA). IPSA block is a pain numbing medication given by surgeon and injected inside the back and inner side of the knee joint. Local Infiltration Analgesia is a pain numbing medication injection given by the surgeon around the surgical knee area. The medications used in the procedure will be EXPAREL, and Bupivacaine HCL. Group 2 (Control): Patients in this group will receive Adductor Canal Block (ACB) and Local Infiltration Analgesia (LIA). ACB is a pain numbing injection given by anesthesiologist near the adductor canal, a passage in the mid-thigh that contains nerves connecting the knee region. Local Infiltration Analgesia is a pain numbing medication injection given by the surgeon around the surgical knee area. The medications used in the procedure will be EXPAREL, and Bupivacaine HCL. Group 3: Patients in this group will receive Local Infiltration Analgesia (LIA). Local Infiltration Analgesia is a pain numbing medication injection given by the surgeon around the surgical knee area. The medications used in the procedure will be EXPAREL, and Bupivacaine HCL. The study will evaluate; * How effective the pain relief is after surgery. * How much extra pain medication you need. * Your satisfaction with pain management and recovery * Any side effects.

Primary Outcome

Patients answer survey questionnaires about knee pain and general health. Pain levels will be taken regularly at 8, 24, 48 and 72 hours after surgery at the healthcare facility. Follow up questionnaire on pain levels will be done at 14 days and 90 days post-surgery. Patients share how satisfied they are with pain management at 72 hours, 14 days and 90 days after surgery. Subject's Reported Pain (Numeric Rating Scale) Pain intensity scores Subject will evaluate their pain in the operative knee u

Conditions Studied

Interventions

  • PROCEDURE Intra-articular Posteromedial Surgeon Administered (IPSA) Block of EXPAREL
  • PROCEDURE Adductor Canal Block (ACB) and Local Local Infiltration Analgesia of EXPAREL
  • PROCEDURE Local Infiltration Analgesia (LIA) of EXPAREL

Study Locations (1)

Ohio

  • Cleveland Clinic Lutheran Hospital - Cleveland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-18
Est. Completion 2026-12-11
Phase NA
The Cleveland Clinic

688 total trials

What NCT06946368 shows while recruiting

NCT06946368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 3 interventions - of which Intra-articular Posteromedial Surgeon Administered (IPSA) Block of EXPAREL is the first listed.

NCT06946368 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06946368 about?

NCT06946368 is a clinical study titled "Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery". Intra-articular Posteromedial Surgeon Administered (IPSA) Block in this study describes a new type of medical procedure where a surgeon provides anesthetic medication directly into a specific area inside a knee joint to numb the pain during knee surgery. Intra-articular refers to inside of knee join...

What is the current status of trial NCT06946368?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-18. Estimated completion is 2026-12-11.

What conditions does trial NCT06946368 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT06946368?

The interventions under investigation include: Intra-articular Posteromedial Surgeon Administered (IPSA) Block of EXPAREL (PROCEDURE), Adductor Canal Block (ACB) and Local Local Infiltration Analgesia of EXPAREL (PROCEDURE), Local Infiltration Analgesia (LIA) of EXPAREL (PROCEDURE).

Who is sponsoring clinical trial NCT06946368?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06946368 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06946368's enrollment target sits among peer trials

60 23rd of 29 higher than 6 of 29 other Total Knee Arthroplasty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06946368, the US trial registry maintained by the National Library of Medicine. NCT06946368 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.